Diabetic Macular Edema Market to Witness a Pronounce Growth During 2017 to 2027
Report overview @ https://www.xploremr.com/report/827/diabetic-macular-edema-market
Growing adoption of recently approved Intravitreal implants in North America
Before the launch of Lucentis for DME treatment in 2012, the use of intravitreally injected medications was less common in North America and laser photocoagulation was the primary treatment. However, Avastin and Macugen were being used off-label for diabetic macular edema treatment since 2004.
Launch of three new products in 2014 viz. Eylea, Ozurdex and Iluvien, has led to the increased adoption of Intravitreal medications in North America. For instance, according to estimates of the University of Washington, before 2004, 5.75% of DME patients used Intravitreal injections, which increased to 20% by 2013. In 2016, over 70% of DME patients were utilising Intravitreal injections and implants.
This sudden increase in the adoption of Intravitreal therapies can be attributed to the launch of low dose high efficacy corticosteroid implants for Intravitreal use. Uptake of Intravitreal implants by new patients as well as by patients previously treated with Intravitreal injections but who do not show any improvement, is expected to push the market for diabetic macular edema in the region.
Growing economic burden of diabetes and related disorders
Diabetic Macular Edema (DME) is a leading cause of blindness among the working age population in most developed countries. DME is one of the major complications of diabetes and DME patients utilise significantly higher healthcare resources than non-DME diabetic patients. As per a survey conducted by the University of Washington, the total yearly median cost for DME patients was reported to be US$ 14,678 and that for non-DME diabetic patients was US$ 6,801 in 2011.
Moreover, DME patients have to visit their physicians for at least 30 days per year in contrast to an average of 14 visits per year in the case of non-DME diabetic patients. The growing incidences of diabetes across the globe further increase the burden of DME. According to the International Diabetic Federation (IDF), 382 Mn people worldwide have diabetes and the number is expected to grow to 592 Mn by 2035.
Gaps in making DME a health priority hampering market growth in North America
Although control of diabetes is made a health priority in developed countries such as the U.S., much attention is not given to DME management and diabetes related caregivers tend to focus on the treatment of other diabetic complications. The major reason for this is the lack of effective treatment for DME. Even though anti-VEGF and corticosteroid therapies have changed the treatment paradigm, there exists a gap in patients’ clinical information among clinicians.
Furthermore, there exists an error in industry sponsored and independently run clinical trials. For instance, there are approximately 72 independent clinical trials going on for DME treatment, but most of them lack long-term results regarding safety and efficacy on new and combination therapies for diabetic macular edema. These factors are hampering revenue growth of the diabetic macular edema market in North America.
Get a free sample request @ https://www.xploremr.com/connectus/sample/827
Global Diabetic Macular Edema Market Attractiveness Analysis, By Region
Western Europe is expected to be the most lucrative market for diabetic macular edema, with market attractiveness index of 2.7. Major players in the diabetic macular edema market, including Bayer AG and Novartis AG, are focussing on improving the sale of Eylea and Lucentis, respectively, in Europe.
Companies are trying to exploit the full market potential and get maximum returns on R&D till patents for their drugs are alive. North America dominated the diabetic macular edema market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. North America is expected to be the second most lucrative among all regions, with an attractiveness index of 2.5.
APEJ represents the third largest market with a market attractiveness index of 0.4. MEA is expected to remain the least attractive regional market for diabetic macular edema in revenue terms, with an attractiveness index of 0.1 over the forecast period.
Buy Now Full Report @ https://www.xploremr.com/cart/reports/buynow/827
XploreMR is one of the world’s leading resellers of high-quality market research reports. We feature in-depth reports from some of the world’s most reputed market research companies and international organizations. We serve across a broad spectrum – from Fortune 500 to small and medium businesses. Our clients trust us for our unwavering focus onquality and affordability. We believe high price should not be a bottleneck for organizations looking to gain access to quality information.
111 North Market Street, Suite 300
San Jose, CA 95113, United States
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Macular Edema Market to Witness a Pronounce Growth During 2017 to 2027 here
News-ID: 1096067 • Views: 150
More Releases from Xplore Market Research
Anti-counterfeit Pharmaceutical Packaging Market Pegged for Robust Expansion Dur …
This report by Future Market Insights on the global anti-counterfeit pharmaceutical packaging market for the period 2016–2026 presents an outlook of the market across the globe. The primary objective of the report is to offer updates on market opportunities in the global anti-counterfeit pharmaceutical packaging market. Report overview @ https://www.xploremr.com/report/1028/anti-counterfeit-pharmaceutical-packaging-market The report is categorically divided into three sections namely, by usage features, by technology and by region, to understand and offer
Pallets Market to Reflect Impressive Growth Rate During 2024
Persistence Market Research analyzes the India Pallets market over an eight year period from 2016 to 2024. The study demonstrates market dynamics and trends across regions that are expected to influence the current status and future prospects of the India Pallets market over the forecast period (2016 - 2024). Report overview @ https://www.xploremr.com/report/977/india-pallets-market The primary objective of the report is to offer information on market drivers, restraints, trends, opportunities, and value
Water Softening Systems Market Set to Witness an Uptick during 2015 to 2025
This report by XploreMR on the ‘Global Water Softening Systems Market’ for the period 2015 - 2025 presents an outlook of the water softening systems market across the globe. The primary objective of the report is to offer updates on the market opportunities in the global water softening systems market. Report overview @ https://www.xploremr.com/report/920/water-softening-systems-market The report provides value (US$ Mn) and volume (units) analysis of the global water softening systems market across
Military Defense Vehicle Intercom System Market to Witness Increase in Revenues …
Fact.MR Report examines global Military Defense Vehicle Intercom System for the forecast period 2017–2027. The prime purpose of the report is to find opportunities and trends in the market and provide insights pertaining to segments of the military defense vehicle intercom systems market. To understand trends and opportunities in military defense vehicle intercom system market, the report is divided into various segments on the basis of intercom type, transmission power type,
More Releases for DME
Durable Medical Equipment (DME) Global Market 2019
Press Release – 30 Jan 2019 Research and Development News -- . . Latest Update "Global Durable Medical Equipment (DME) Market By Type, By Therapeutic and monitoring Devices Type, By End User, By Region, By Country (2018 Edition) - Forecast to 2023-By Type (Personal Mobility devices, Therapeutic and Monitoring Devices, Medical Furniture, Others), By Sub-Type (Oxygen Equipment, Blood Sugar Monitors, Continuous Passive Motions, Nebulizers, Other Devices), By End User (Hospitals and Clinics,
Global Durable Medical Equipment (DME) Market (2018 Edition)
Global Research and Development News -- . . "Global Durable Medical Equipment (DME) Market By Type, By Therapeutic and monitoring Devices Type, By End User, By Region, By Country (2018 Edition) - Forecast to 2023-By Type (Personal Mobility devices, Therapeutic and Monitoring Devices, Medical Furniture, Others), By Sub-Type (Oxygen Equipment, Blood Sugar Monitors, Continuous Passive Motions, Nebulizers, Other Devices), By End User (Hospitals and Clinics, Long Term Care Services, Home Care Services,
Dimethyl Ether (DME) Market 2022 Global Analysis, Opportunities and Forecast
Dimethyl Ether (DME) is an ether which has the largest application in chemical industry. It is produced using fossil fuels, methanol, and biomass. However, the most prominent raw material used in producing DME is coal. Having various properties similar to Liquefied Petroleum Gas (LPG) it is being considered as an excellent alternative to the traditional fuel. Many countries are moving towards using dimethyl ether, reducing their dependency LPG. Various plans
Dimethyl Ether (DME) Market Demands and Growth Prediction 2017-2022
Qyresearchreports include new market research report Global Dimethyl Ether (DME) Market Research Report 2017 to its huge collection of research reports. This report on the global Dimethyl Ether (DME) market has been developed by a selected group of professional market research analysts, with a solitary goal to present the current scenario of the market for Dimethyl Ether (DME) and throw light on its growth prospects. The report targets audiences such as
Dimethyl Ether (DME) Market Global Report, Application & Research 2025
DME is a substitute to conventional energizes and holds colossal potential crosswise over boundless applications. The most critical item utilize is mixing condensed oil gas (LPG). The organization of LPG and DME shares different likenesses, which makes it conceivable to adjust the two in square with extents with no adjustment in the resultant fuel. This one of a kind trademark makes mixed LPG suited for wide assortment use in hardware
Dimethyl Ether (DME) Market - Current Scenario and Forecast 2017 - 2025
Dimethyl Ether (DME) Market: Snapshot Majority of the DME manufactured these days is an end-product of two-step process where the first step involves methanol generation with the help of natural gas or coal being used a feedstock. And the second step involves dehydration of methanol for the production of DME. Dimethyl Ether has the potential of replacing diesel in the conventional engines with small modifications that need to be made in